CDRE

Cadre Holdings, Inc. CDRE

NYSESmall CapHealthcare

13F Pro quality score

Rank #1,083 of 2,925TOP 50%

Why it scores 58Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$207.13M

Quarter to Jun 30

Net income

$11.41M

Quarter to Jun 30

Free cash flow

$18.68M

Quarter to Jun 30

Operating margin

10.8%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$943.02M total
BlackRock, Inc.
$83.73M+11.8%
Greenhouse Funds LLLP
$81.79M0.0%
REINHART PARTNERS, LLC.
$78.07M+22.4%
FMR LLC
$70.58M-25.4%
STATE STREET CORP
$55.59M+39.6%
Capital International Investors
$46.26M+28.7%
VANGUARD CAPITAL MANAGEMENT LLC
$37.75M+6.2%
GW&K Investment Management, LLC
$36.33M+21.7%
Capital World Investors
$34.36M+2.8%
WYNNEFIELD CAPITAL INC
$34.35M+4.8%
Select Equity Group, L.P.
$33.70M+57.9%
BROWN ADVISORY INC
$28.12M+15.2%
DIMENSIONAL FUND ADVISORS LP
$23.62M+8.0%
GEODE CAPITAL MANAGEMENT, LLC
$22.06M+12.6%
MORGAN STANLEY
$20.80M-2.9%
Capital Research Global Investors
$19.56M+16.6%
BANK OF AMERICA CORP /DE/
$18.98M+18.3%
R.P. Boggs & Co.
$17.05M+129.7%
RAYMOND JAMES FINANCIAL INC
$11.67M-19.3%
Invesco Ltd.
$9.50M+15.0%
First Eagle Investment Management, LLC
$8.74MNew
NORTHERN TRUST CORP
$8.52M-0.1%
CRAWFORD INVESTMENT COUNSEL INC
$8.52M+5.6%
AGMAN CAPITAL LLC
$7.34M+20.4%
VANGUARD PORTFOLIO MANAGEMENT LLC
$7.32M+25.6%
See all 157 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CDRE

Earnings Per Share

13fpro.ai/company/CDRE

Loading ratio trend…

CDRE key financials by period

Reported revenue, net income and operating margin by fiscal year, from Cadre Holdings, Inc.'s annual filings on SEC EDGAR.

Cadre Holdings, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$610.3M$44.1M11.0%
FY 2024$567.6M$36.1M11.8%
FY 2023$482.5M$38.6M11.7%
FY 2022$457.8M$5.8M3.6%
FY 2021$427.3M$12.7M12.1%
FY 2020$404.6M$38.5M12.3%
Source: CDRE filings on SEC EDGAR →

Companies similar to CDRE

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

CDRE insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in CDRE

6 transactions in CDRE reported by 2 members of Congress under the STOCK Act, most recent trade Mar 16, 2026. Reported transactions, not recommendations.

All Congress stock trades →

About Cadre Holdings, Inc. (CDRE): stock profile, AI score and financials

Cadre Holdings, Inc. (CDRE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CDRE at 57.6/100 on a composite quality score built from its SEC filings, placing it at rank #1,083 of 2,925 stocks — the top half of the AI-ranked universe. CDRE scores in the top quartile across earnings quality (86.8). Shareholder dilution risk is elevated at 39.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Cadre Holdings, Inc. reports quarterly revenue of $207.1M, net income of $11.4M, an operating margin of 10.8%. CDRE trades on the NYSE exchange and files with the SEC under CIK 1860543. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CDRE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cadre Holdings, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1860543 →